{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T13:12:42Z","timestamp":1790082762322,"version":"4.0.1"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,7,7]],"date-time":"2022-07-07T00:00:00Z","timestamp":1657152000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,7,7]],"date-time":"2022-07-07T00:00:00Z","timestamp":1657152000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>The potential effects of opium consumption on lipid profile remain unquantified. We considered the association between opium use and dyslipidemia. In this cross-sectional study, we used data obtained from the Rafsanjan cohort study, as a part of the prospective epidemiological research studies in IrAN (PERSIAN) with detailed and validated data on opium consumption and selected other exposures. A total of 9932 adults were included in the study. Logistic regression models were used to assess the relationships of opium consumption with the prevalence of dyslipidemia and lipid disorders. In this population, 73.33% had dyslipidemia and the prevalence rates of high TC, high TG, high LDL and low HDL were 54.24%, 47.45%, 34.43% and 11.91% respectively. After adjustment for all confounders, opium users compared with non-users had lower odds ratios (OR) of high TC and high LDL [0.81 (95% confidence interval, CI 0.71\u20130.92) and 0.80 (95% CI 0.69\u20130.93) respectively] and greater OR of low HDL [1.30 (95% CI 1.04\u20131.62)]. Longer duration of opium consumption resulted in lower ORs of high TC, 0.68 (95% CI 0.55\u20130.84) and high LDL, 0.82 (95% CI 0.67\u20130.99), and shorter duration of opium consumption resulted in increased odds of low HDL, 1.30 (95% CI 1.02\u20131.66). High dose of opium consumption was associated with an OR of dyslipidemia of 0.80 (95% CI 0.65\u20130.97), high TC of 0.80 (95% CI 0.67\u20130.95), and high LDL of 0.78 (95% CI 0.64\u20130.96) and low dose of opium consumption, with an OR of low HDL of 1.30 (95% CI 1.02\u20131.65). In relation to route of consumption, opium smoking was a risk factor for low HDL with an adjusted odds ratio of 1.31 (1.04\u20131.63). Opium use was associated with selected changes on serum lipid levels, but opium users had higher frequency of cardiovascular disease history.<\/jats:p>","DOI":"10.1038\/s41598-022-13926-3","type":"journal-article","created":{"date-parts":[[2022,7,7]],"date-time":"2022-07-07T07:03:22Z","timestamp":1657177402000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Prevalence of dyslipidemia and its association with opium consumption in the Rafsanjan cohort study"],"prefix":"10.1038","volume":"12","author":[{"given":"Zahra","family":"Jamali","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mojgan","family":"Noroozi Karimabad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Parvin","family":"Khalili","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tabandeh","family":"Sadeghi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmadreza","family":"Sayadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Faegheh","family":"Mohammadakbari Rostamabadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlo","family":"La Vecchia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Esmaeili-Nadimi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,7,7]]},"reference":[{"issue":"8","key":"13926_CR1","doi-asserted-by":"publisher","first-page":"e22579","DOI":"10.1002\/jcla.22579","volume":"32","author":"S Darroudi","year":"2018","unstructured":"Darroudi, S. et al. Prevalence of combined and noncombined dyslipidemia in an Iranian population. J. Clin. Lab. Anal. 32(8), e22579 (2018).","journal-title":"J. Clin. Lab. Anal."},{"issue":"1","key":"13926_CR2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-020-79139-8","volume":"11","author":"C Huang","year":"2021","unstructured":"Huang, C. et al. Prevalence and related factors of dyslipidemia among urban adults aged 35 to 79 years in Southwestern China. Sci. Rep. 11(1), 1\u20138 (2021).","journal-title":"Sci. Rep."},{"issue":"5","key":"13926_CR3","first-page":"449","volume":"43","author":"MA Toori","year":"2018","unstructured":"Toori, M. A. et al. Prevalence of hypercholesterolemia, high LDL, and low HDL in Iran: A systematic review and meta-analysis. Iran. J. Med. Sci. 43(5), 449 (2018).","journal-title":"Iran. J. Med. Sci."},{"issue":"1","key":"13926_CR4","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1186\/1756-0500-4-531","volume":"4","author":"ME Modelli","year":"2011","unstructured":"Modelli, M. E., Cherulli, \u00c1. S., Gandolfi, L. & Pratesi, R. Atherosclerosis in young Brazilians suffering violent deaths: a pathological study. BMC. Res. Notes 4(1), 531 (2011).","journal-title":"BMC. Res. Notes"},{"issue":"4","key":"13926_CR5","doi-asserted-by":"publisher","first-page":"529","DOI":"10.2337\/dc16-1958","volume":"40","author":"JS Lee","year":"2017","unstructured":"Lee, J. S. et al. Triglyceride and HDL-C dyslipidemia and risks of coronary heart disease and ischemic stroke by glycemic dysregulation status: the strong heart study. Diabetes Care 40(4), 529\u2013537 (2017).","journal-title":"Diabetes Care"},{"issue":"1","key":"13926_CR6","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1186\/s12944-018-0768-7","volume":"17","author":"X Liu","year":"2018","unstructured":"Liu, X. et al. Dyslipidemia prevalence, awareness, treatment, control, and risk factors in Chinese rural population: the Henan rural cohort study. Lipids Health Dis. 17(1), 119 (2018).","journal-title":"Lipids Health Dis."},{"key":"13926_CR7","doi-asserted-by":"publisher","first-page":"436","DOI":"10.3389\/fphys.2016.00436","volume":"7","author":"H Najafipour","year":"2016","unstructured":"Najafipour, H. & Beik, A. The impact of opium consumption on blood glucose, serum lipids and blood pressure, and related mechanisms. Front. Physiol. 7, 436 (2016).","journal-title":"Front. Physiol."},{"issue":"1","key":"13926_CR8","first-page":"14","volume":"11","author":"G Yousefzadeh","year":"2015","unstructured":"Yousefzadeh, G., Shokoohi, M., Najafipour, H., Eslami, M. & Salehi, F. Association between opium use and metabolic syndrome among an urban population in Southern Iran: results of the Kerman Coronary Artery Disease Risk Factor Study (KERCADRS). ARYA Atherosclerosis 11(1), 14 (2015).","journal-title":"ARYA Atherosclerosis"},{"key":"13926_CR9","doi-asserted-by":"crossref","unstructured":"Ziaaddini, H., Ziaaddini, T. & Nakhaee, N. Pattern and trend of substance abuse in eastern rural Iran: A household survey in a rural community. J. Addict. 2013 (2013).","DOI":"10.1155\/2013\/297378"},{"issue":"1","key":"13926_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12889-016-3760-z","volume":"16","author":"M Farjam","year":"2016","unstructured":"Farjam, M. et al. A cohort study protocol to analyze the predisposing factors to common chronic non-communicable diseases in rural areas: Fasa Cohort Study. BMC Public Health 16(1), 1\u20138 (2016).","journal-title":"BMC Public Health"},{"key":"13926_CR11","first-page":"310","volume":"7","author":"S Mami","year":"2011","unstructured":"Mami, S. et al. Effect of opium addiction on some serum parameters in rabbit. Glob Vet. 7, 310\u2013314 (2011).","journal-title":"Glob Vet."},{"issue":"3","key":"13926_CR12","first-page":"169","volume":"3","author":"SS Fatemi","year":"2008","unstructured":"Fatemi, S. S., Hasanzadeh, M., Arghami, A. & Sargolzaee, M. R. Lipid profile comparison between opium addicts and non-addicts. J. Tehran Univ. Heart Center. 3(3), 169\u2013172 (2008).","journal-title":"J. Tehran Univ. Heart Center."},{"issue":"1","key":"13926_CR13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13011-019-0249-7","volume":"15","author":"S Nakhaee","year":"2020","unstructured":"Nakhaee, S. et al. The effects of opium on the cardiovascular system: a review of side effects, uses, and potential mechanisms. Substance Abuse Treat. Prevent. Policy 15(1), 1\u201313 (2020).","journal-title":"Substance Abuse Treat. Prevent. Policy"},{"issue":"1","key":"13926_CR14","first-page":"585","volume":"4","author":"MRK Niaki","year":"2013","unstructured":"Niaki, M. R. K., Hamid, M., Farshidi, F., Mohammadpour, M. & Omran, M. T. S. Evaluation of the role of opium addiction in acute myocardial infarction as a risk factor. Caspian J. Intern. Med. 4(1), 585 (2013).","journal-title":"Caspian J. Intern. Med."},{"issue":"1","key":"13926_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12872-020-01788-4","volume":"21","author":"P Khalili","year":"2021","unstructured":"Khalili, P. et al. Effect of opium consumption on cardiovascular diseases\u2014A cross-sectional study based on data of Rafsanjan cohort study. BMC Cardiovasc. Disord. 21(1), 1\u201311 (2021).","journal-title":"BMC Cardiovasc. Disord."},{"issue":"10","key":"13926_CR16","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.1016\/j.amjcard.2004.01.072","volume":"93","author":"M Marmor","year":"2004","unstructured":"Marmor, M., Penn, A., Widmer, K., Levin, R. I. & Maslansky, R. Coronary artery disease and opioid use. Am. J. Cardiol. 93(10), 1295\u20131297 (2004).","journal-title":"Am. J. Cardiol."},{"issue":"1","key":"13926_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-021-88680-z","volume":"11","author":"M Nikparvar","year":"2021","unstructured":"Nikparvar, M. et al. Dyslipidemia and its associated factors in southern Iranian women, Bandare-Kong Cohort study, a cross-sectional survey. Sci. Rep. 11(1), 1\u201311 (2021).","journal-title":"Sci. Rep."},{"key":"13926_CR18","doi-asserted-by":"crossref","unstructured":"Abujbara, M., Batieha, A., Khader, Y., Jaddou, H., El-Khateeb, M. & Ajlouni, K. The Prevalence of dyslipidemia among Jordanians. J. Lipids. 2018 (2018).","DOI":"10.1155\/2018\/6298739"},{"issue":"3","key":"13926_CR19","doi-asserted-by":"publisher","first-page":"219","DOI":"10.2217\/clp.15.16","volume":"10","author":"E Rink\u016bnien\u0117","year":"2015","unstructured":"Rink\u016bnien\u0117, E. et al. The prevalence of dislipidemia and its relation to other risk factors: a nationwide survey of Lithuania. Clin. Lipidol. 10(3), 219\u2013225 (2015).","journal-title":"Clin. Lipidol."},{"issue":"4","key":"13926_CR20","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1093\/aje\/kwx314","volume":"187","author":"H Poustchi","year":"2018","unstructured":"Poustchi, H. et al. Prospective epidemiological research studies in Iran (the PERSIAN Cohort Study): Rationale, objectives, and design. Am. J. Epidemiol. 187(4), 647\u2013655 (2018).","journal-title":"Am. J. Epidemiol."},{"key":"13926_CR21","unstructured":"Hakimi, H., Ahmadi, J., Vakilian, A., Jamalizadeh, A., Kamyab, Z., Mehran, M. et al. The profile of Rafsanjan Cohort Study. Eur. J. Epidemiol. 1\u201310 (2020)."},{"issue":"1","key":"13926_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-021-91533-4","volume":"11","author":"M Kazemi","year":"2021","unstructured":"Kazemi, M. et al. Lipid profile dysregulation in opium users based on Fasa PERSIAN cohort study results. Sci. Rep. 11(1), 1\u20139 (2021).","journal-title":"Sci. Rep."},{"issue":"1","key":"13926_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12944-020-01354-z","volume":"19","author":"M Rezaei","year":"2020","unstructured":"Rezaei, M., Fakhri, N., Pasdar, Y., Moradinazar, M. & Najafi, F. Modeling the risk factors for dyslipidemia and blood lipid indices: Ravansar cohort study. Lipids Health Dis. 19(1), 1\u20138 (2020).","journal-title":"Lipids Health Dis."},{"issue":"3","key":"13926_CR24","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.dsx.2016.01.009","volume":"10","author":"H Ebrahimi","year":"2016","unstructured":"Ebrahimi, H., Emamian, M. H., Hashemi, H. & Fotouhi, A. Dyslipidemia and its risk factors among urban middle-aged Iranians: A population-based study. Diabetes Metab. Syndr. 10(3), 149\u2013156 (2016).","journal-title":"Diabetes Metab. Syndr."},{"issue":"4","key":"13926_CR25","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1016\/j.clinthera.2007.04.009","volume":"29","author":"RJ Petrella","year":"2007","unstructured":"Petrella, R. J., Merikle, E. & Jones, J. Prevalence and treatment of dyslipidemia in Canadian primary care: A retrospective cohort analysis. Clin. Ther. 29(4), 742\u2013750 (2007).","journal-title":"Clin. Ther."},{"key":"13926_CR26","doi-asserted-by":"crossref","unstructured":"Khademi H, Malekzadeh R, Pourshams A, Jafari E, Salahi R, Semnani S, et al. Opium use and mortality in Golestan Cohort Study: prospective cohort study of 50 000 adults in Iran. BMJ. 2012;344.","DOI":"10.1136\/bmj.e2502"},{"issue":"2","key":"13926_CR27","doi-asserted-by":"publisher","first-page":"425","DOI":"10.26719\/2009.15.2.425","volume":"15","author":"A Meysamie","year":"2009","unstructured":"Meysamie, A., Sedaghat, M., Mahmoodi, M., Ghodsi, S. & Eftekhar, B. Opium use in a rural area of the Islamic Republic of Iran. EMHJ-Eastern Mediterr. Health J. 15(2), 425\u2013431 (2009).","journal-title":"EMHJ-Eastern Mediterr. Health J."},{"issue":"4","key":"13926_CR28","first-page":"305","volume":"3","author":"Z Rezaei","year":"2014","unstructured":"Rezaei, Z., Zarei, F., Firoozi, E. & Ahmadi, D. Pattern of illegal drug use in women referred to substance abuse control Clinic in Fasa, Iran (2009\u20132011). J. Fasa Univ. Med. Sci. 3(4), 305\u2013311 (2014).","journal-title":"J. Fasa Univ. Med. Sci."},{"issue":"1\u20132","key":"13926_CR29","first-page":"54","volume":"7","author":"MH Gozashti","year":"2015","unstructured":"Gozashti, M. H., Yazdi, F., Salajegheh, P., Dehesh, M. M. & Divsalar, K. Fasting blood glucose and insulin level in opium addict versus non-addict individuals. Addict. Health. 7(1\u20132), 54 (2015).","journal-title":"Addict. Health."},{"issue":"3\u20134","key":"13926_CR30","first-page":"138","volume":"6","author":"MR Afarinesh","year":"2014","unstructured":"Afarinesh, M. R. et al. Changes in serum biochemical factors associated with opium addiction after addiction desertion. Addict. Health. 6(3\u20134), 138 (2014).","journal-title":"Addict. Health."},{"issue":"3\u20134","key":"13926_CR31","first-page":"149","volume":"7","author":"M Masoomi","year":"2015","unstructured":"Masoomi, M., Azdaki, N. & Shahouzehi, B. Elevated plasma homocysteine concentration in opium-addicted individuals. Addict. Health. 7(3\u20134), 149 (2015).","journal-title":"Addict. Health."},{"issue":"2","key":"13926_CR32","doi-asserted-by":"publisher","first-page":"e22702","DOI":"10.5812\/ijhrba.22702","volume":"4","author":"DB Sanli","year":"2015","unstructured":"Sanli, D. B. et al. Effect of different psychoactive substances on serum biochemical parameters. Int. J. High Risk Behav. Addict. 4(2), e22702 (2015).","journal-title":"Int. J. High Risk Behav. Addict."},{"issue":"1","key":"13926_CR33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1476-511X-7-42","volume":"7","author":"S Asgary","year":"2008","unstructured":"Asgary, S., Sarrafzadegan, N., Naderi, G.-A. & Rozbehani, R. Effect of opium addiction on new and traditional cardiovascular risk factors: do duration of addiction and route of administration matter?. Lipids Health Dis. 7(1), 1\u20135 (2008).","journal-title":"Lipids Health Dis."},{"key":"13926_CR34","doi-asserted-by":"publisher","first-page":"12","DOI":"10.4103\/2277-9175.148294","volume":"4","author":"O Aghadavoudi","year":"2015","unstructured":"Aghadavoudi, O., Eizadi-Mood, N. & Najarzadegan, M. R. Comparing cardiovascular factors in opium abusers and non-users candidate for coronary artery bypass graft surgery. Adv. Biomed. Res. 4, 12 (2015).","journal-title":"Adv. Biomed. Res."},{"key":"13926_CR35","first-page":"50","volume":"4","author":"TM Salman","year":"2010","unstructured":"Salman, T. M. et al. Oxidative stress and lipotoxicity of bhang and opium addiction. Effects on adrenal gland secretions. Dyn. Biochem. Proc. Biotechnol. Mol. Biol. 4, 50\u201354 (2010).","journal-title":"Dyn. Biochem. Proc. Biotechnol. Mol. Biol."},{"key":"13926_CR36","doi-asserted-by":"publisher","first-page":"1870","DOI":"10.1055\/s-0031-1280017","volume":"77","author":"SK Hosseini","year":"2011","unstructured":"Hosseini, S. K. et al. Opium consumption and coronary atherosclerosis in diabetic patients: A propensity score-matched study. Planta Med. 77, 1870\u20131875 (2011).","journal-title":"Planta Med."},{"issue":"2","key":"13926_CR37","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.etp.2008.08.001","volume":"61","author":"A Mohammadi","year":"2009","unstructured":"Mohammadi, A. et al. Effect of opium addiction on lipid profile and atherosclerosis formation in hypercholesterolemic rabbits. Exp. Toxicol. Pathol. 61(2), 145\u2013149 (2009).","journal-title":"Exp. Toxicol. Pathol."},{"issue":"2","key":"13926_CR38","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/j.jep.2009.11.011","volume":"127","author":"H Najafipour","year":"2010","unstructured":"Najafipour, H., Joukar, S., Malekpour-Afshar, R., Mirzaeipour, F. & Nasri, H. R. Passive opium smoking does not have beneficial effect on plasma lipids and cardiovascular indices in hypercholesterolemic rabbits with ischemic and non-ischemic hearts. J. Ethnopharmacol. 127(2), 257\u2013263 (2010).","journal-title":"J. Ethnopharmacol."},{"issue":"1","key":"13926_CR39","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/S0740-5472(03)00141-7","volume":"26","author":"J Ahmadi","year":"2004","unstructured":"Ahmadi, J., Babaee-Beigi, M., Alishahi, M., Maany, I. & Hidari, T. Twelve-month maintenance treatment of opium-dependent patients. J. Subst. Abuse Treat. 26(1), 61\u201364 (2004).","journal-title":"J. Subst. Abuse Treat."},{"issue":"3","key":"13926_CR40","doi-asserted-by":"publisher","first-page":"135","DOI":"10.3109\/00952991003734277","volume":"36","author":"D Kouros","year":"2010","unstructured":"Kouros, D., Tahereh, H., Mohammadreza, A. & Minoo, M. Z. Opium and heroin alter biochemical parameters of human\u2019s serum. Am. J. Drug Alcohol Abuse 36(3), 135\u2013139 (2010).","journal-title":"Am. J. Drug Alcohol Abuse"},{"issue":"19","key":"13926_CR41","doi-asserted-by":"publisher","first-page":"3777","DOI":"10.1016\/0006-2952(88)90415-7","volume":"37","author":"HU Bryant","year":"1988","unstructured":"Bryant, H. U., Kuta, C. C., Story, J. A. & Yim, G. K. Stress-and morphine-induced elevations of plasma and tissue cholesterol in mice: Reversal by naltrexone. Biochem. Pharmacol. 37(19), 3777\u20133780 (1988).","journal-title":"Biochem. Pharmacol."},{"issue":"2","key":"13926_CR42","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1111\/j.1742-7843.2004.950202.x","volume":"95","author":"YT Zhang","year":"2004","unstructured":"Zhang, Y. T., Zheng, Q. S., Pan, J. & Zheng, R. L. Oxidative damage of biomolecules in mouse liver induced by morphine and protected by antioxidants. Basic Clin. Pharmacol. Toxicol. 95(2), 53\u201358 (2004).","journal-title":"Basic Clin. Pharmacol. Toxicol."},{"key":"13926_CR43","first-page":"150","volume":"12","author":"G Ili\u0107","year":"2005","unstructured":"Ili\u0107, G., Karad\u017ei\u0107, R., Kosti\u0107-Banovi\u0107, L. & Stojanovi\u0107, J. Chronic intravenous heroin abuse: impact on the liver. Med Biol. 12, 150\u2013153 (2005).","journal-title":"Med Biol."},{"issue":"4","key":"13926_CR44","first-page":"285","volume":"10","author":"MR Ghadir","year":"2010","unstructured":"Ghadir, M. R., Riahin, A. A., Havaspour, A., Nooranipour, M. & Habibinejad, A. A. The relationship between lipid profile and severity of liver damage in cirrhotic patients. Hepat. Mon. 10(4), 285 (2010).","journal-title":"Hepat. Mon."},{"issue":"2","key":"13926_CR45","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/0376-8716(91)90047-3","volume":"29","author":"S Maccari","year":"1991","unstructured":"Maccari, S., Bassi, C., Zanoni, P. & Plancher, A. C. Plasma cholesterol and triglycerides in heroin addicts. Drug Alcohol Depend. 29(2), 183\u2013187 (1991).","journal-title":"Drug Alcohol Depend."},{"issue":"4","key":"13926_CR46","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1080\/13556210500351263","volume":"10","author":"GR Moshtaghi-Kashanian","year":"2005","unstructured":"Moshtaghi-Kashanian, G. R., Esmaeeli, F. & Dabiri, S. Enhanced prolactin levels in opium smokers. Addict. Biol. 10(4), 345\u2013349 (2005).","journal-title":"Addict. Biol."},{"issue":"1","key":"13926_CR47","first-page":"461","volume":"15","author":"MS Hamrah","year":"2021","unstructured":"Hamrah, M. S. et al. Impact of opium use on the conventional coronary artery risk factors among outpatients in Afghanistan: A case-control study In Andkhoy City. Pak. J. Med. Health Sci. 15(1), 461\u2013467 (2021).","journal-title":"Pak. J. Med. Health Sci."},{"issue":"5","key":"13926_CR48","doi-asserted-by":"publisher","first-page":"e649","DOI":"10.1016\/S2214-109X(20)30059-0","volume":"8","author":"M Sheikh","year":"2020","unstructured":"Sheikh, M. et al. Opium use and subsequent incidence of cancer: results from the Golestan Cohort Study. Lancet Glob. Health 8(5), e649\u2013e660 (2020).","journal-title":"Lancet Glob. Health"},{"issue":"12","key":"13926_CR49","first-page":"2154","volume":"48","author":"M Ziaee","year":"2019","unstructured":"Ziaee, M. et al. Cardiovascular complications of chronic opium consumption: A narrative review article. Iran. J. Public Health 48(12), 2154 (2019).","journal-title":"Iran. J. Public Health"},{"key":"13926_CR50","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.drugalcdep.2014.05.001","volume":"141","author":"J Gryczynski","year":"2014","unstructured":"Gryczynski, J., Schwartz, R. P., Mitchell, S. G., O\u2019Grady, K. E. & Ondersma, S. J. Hair drug testing results and self-reported drug use among primary care patients with moderate-risk illicit drug use. Drug Alcohol Depend. 141, 44\u201350 (2014).","journal-title":"Drug Alcohol Depend."},{"key":"13926_CR51","doi-asserted-by":"crossref","unstructured":"Harrison LD, Hughes A. The validity of self-reported drug use: Improving the accuracy of survey estimates: US Department of Health and Human Services, National Institutes of Health\u00a0\u2026; 1997.","DOI":"10.1037\/e495622006-002"},{"issue":"2","key":"13926_CR52","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1080\/02791072.2003.10400010","volume":"35","author":"GS Yacoubian","year":"2003","unstructured":"Yacoubian, G. S., VanderWall, K. L., Johnson, R. J., Urbach, B. J. & Peters, R. J. Comparing the validity of self-reported recent drug use between adult and juvenile arrestees. J. Psychoact. Drugs 35(2), 279\u2013284 (2003).","journal-title":"J. Psychoact. Drugs"},{"issue":"5","key":"13926_CR53","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1037\/0033-2909.133.5.859","volume":"133","author":"R Tourangeau","year":"2007","unstructured":"Tourangeau, R. & Yan, T. Sensitive questions in surveys. Psychol. Bull. 133(5), 859 (2007).","journal-title":"Psychol. Bull."},{"issue":"9","key":"13926_CR54","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.3109\/10826089609063969","volume":"31","author":"S Magura","year":"1996","unstructured":"Magura, S. & Kang, S.-Y. Validity of self-reported drug use in high risk populations: a meta-analytical review. Subst. Use Misuse 31(9), 1131\u20131153 (1996).","journal-title":"Subst. Use Misuse"},{"issue":"1","key":"13926_CR55","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13011-020-00336-9","volume":"16","author":"P Khalili","year":"2021","unstructured":"Khalili, P. et al. Validity of self-reported substance use: Research setting versus primary health care setting. Subst. Abuse Treat. Prevent. Policy 16(1), 1\u201313 (2021).","journal-title":"Subst. Abuse Treat. Prevent. Policy"},{"issue":"2","key":"13926_CR56","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1007\/s10654-020-00668-7","volume":"36","author":"H Hakimi","year":"2021","unstructured":"Hakimi, H. et al. The profile of Rafsanjan cohort study. Eur. J. Epidemiol. 36(2), 243\u2013252 (2021).","journal-title":"Eur. J. Epidemiol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-13926-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-13926-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-13926-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,25]],"date-time":"2022-11-25T01:36:58Z","timestamp":1669340218000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-13926-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,7]]},"references-count":56,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["13926"],"URL":"https:\/\/doi.org\/10.1038\/s41598-022-13926-3","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7,7]]},"assertion":[{"value":"11 October 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 May 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 July 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"11504"}}